Coho Partners Ltd. Has $14.36 Million Stock Position in Colgate-Palmolive (NYSE:CL)

Coho Partners Ltd. lowered its stake in Colgate-Palmolive (NYSE:CL) by 23.0% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 138,305 shares of the company’s stock after selling 41,405 shares during the period. Colgate-Palmolive makes up 0.5% of Coho Partners Ltd.’s holdings, making the stock its 29th biggest holding. Coho Partners Ltd.’s holdings in Colgate-Palmolive were worth $14,357,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. E Fund Management Hong Kong Co. Ltd. bought a new position in shares of Colgate-Palmolive in the second quarter worth about $25,000. Continuum Advisory LLC boosted its position in Colgate-Palmolive by 46.5% in the second quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock valued at $38,000 after buying an additional 125 shares in the last quarter. Register Financial Advisors LLC acquired a new stake in Colgate-Palmolive in the first quarter valued at approximately $48,000. Gradient Investments LLC grew its stake in shares of Colgate-Palmolive by 150.4% during the second quarter. Gradient Investments LLC now owns 666 shares of the company’s stock worth $65,000 after buying an additional 400 shares during the last quarter. Finally, Financial Connections Group Inc. acquired a new position in shares of Colgate-Palmolive during the second quarter worth $68,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

Analyst Ratings Changes

Several research firms recently weighed in on CL. Stifel Nicolaus raised their price objective on Colgate-Palmolive from $95.00 to $105.00 and gave the company a “buy” rating in a report on Monday, July 22nd. Hsbc Global Res downgraded Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 26th. Redburn Atlantic raised shares of Colgate-Palmolive to a “hold” rating in a report on Thursday, August 1st. Morgan Stanley raised their price target on shares of Colgate-Palmolive from $103.00 to $111.00 and gave the company an “overweight” rating in a research note on Monday, July 29th. Finally, Jefferies Financial Group cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and reduced their price objective for the stock from $103.00 to $95.00 in a research note on Wednesday, July 24th. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have given a buy rating to the company’s stock. According to data from MarketBeat, Colgate-Palmolive currently has a consensus rating of “Moderate Buy” and an average price target of $106.00.

Colgate-Palmolive Price Performance

Shares of CL opened at $98.98 on Thursday. The stock has a market cap of $81.21 billion, a P/E ratio of 31.32, a P/E/G ratio of 3.54 and a beta of 0.40. The business’s fifty day moving average is $103.31 and its 200 day moving average is $97.84. The company has a quick ratio of 0.70, a current ratio of 1.06 and a debt-to-equity ratio of 16.90. Colgate-Palmolive has a 12-month low of $71.46 and a 12-month high of $109.30.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, July 26th. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.87 by $0.04. The business had revenue of $5.06 billion during the quarter, compared to the consensus estimate of $5 billion. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. Colgate-Palmolive’s revenue was up 4.9% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.77 earnings per share. Sell-side analysts anticipate that Colgate-Palmolive will post 3.57 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 2.02%. The ex-dividend date of this dividend is Friday, October 18th. Colgate-Palmolive’s dividend payout ratio is presently 63.29%.

Insider Buying and Selling

In related news, insider Sally Massey sold 15,850 shares of the company’s stock in a transaction that occurred on Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total value of $1,636,988.00. Following the transaction, the insider now owns 13,942 shares in the company, valued at approximately $1,439,929.76. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other news, insider Sally Massey sold 15,850 shares of Colgate-Palmolive stock in a transaction dated Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total value of $1,636,988.00. Following the completion of the transaction, the insider now owns 13,942 shares in the company, valued at $1,439,929.76. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Martina Hundmejean sold 2,313 shares of the stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the sale, the director now owns 11,755 shares in the company, valued at approximately $1,220,874.30. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 43,490 shares of company stock worth $4,486,063. Insiders own 0.34% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.